ruthenium has been researched along with Leukemia, Promyelocytic, Acute in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista, AA; Bezerra, DP; Bomfim, LM; Correa, RS; de Araujo, FA; Dias, RB; Rocha, CAG; Sales, CBS; Soares, MBP | 1 |
| Bryszewska, M; de la Mata, FJ; Ihnatsyeu-Kachan, A; Ionov, M; Loznikova, S; Maly, M; Maroto-Díaz, M; Michlewska, S; Ramirez, RG; Shcharbin, D; Szwed, A | 1 |
| Abashkin, V; Bryszewska, M; de la Mata, FJ; Denel, M; Dzmitruk, V; Gapinska, M; Gomez Ramirez, R; Ihnatsyeu-Kachan, A; Ionov, M; Maroto-Díaz, M; Michlewska, S; Rogalska, A; Shcharbin, D; Szwed, A | 1 |
3 other study(ies) available for ruthenium and Leukemia, Promyelocytic, Acute
| Article | Year |
|---|---|
Ruthenium(II) complexes with 6-methyl-2-thiouracil selectively reduce cell proliferation, cause DNA double-strand break and trigger caspase-mediated apoptosis through JNK/p38 pathways in human acute promyelocytic leukemia cells.
Topics: Animals; Apoptosis; Caspases; Cell Proliferation; Coordination Complexes; DNA Breaks, Double-Stranded; Female; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; MAP Kinase Signaling System; Mice; Phosphorylation; Ruthenium; Thiouracil; Xenograft Model Antitumor Assays | 2019 |
Ruthenium dendrimers as carriers for anticancer siRNA.
Topics: Absorption, Physiological; Antineoplastic Agents; Circular Dichroism; Dendrimers; Drug Stability; Dynamic Light Scattering; HL-60 Cells; Humans; Intercalating Agents; Leukemia, Promyelocytic, Acute; Microscopy, Electron, Transmission; Models, Molecular; Molecular Conformation; Molecular Dynamics Simulation; Molecular Structure; Particle Size; RNA Interference; RNA Stability; RNA, Small Interfering; Ruthenium; Silanes; Surface Properties | 2018 |
Ruthenium dendrimers against acute promyelocytic leukemia:
Topics: Antineoplastic Agents; Cell Proliferation; Cell Survival; Dendrimers; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Molecular Structure; Organometallic Compounds; Reactive Oxygen Species; Ruthenium; Structure-Activity Relationship | 2019 |